(Press-News.org) PULLMAN, Wash. – A quick, affordable diagnostic test developed by a Washington State University researcher may help curb one of the most prevalent but least discussed sexually transmitted infections.
More common than chlamydia or gonorrhea, Trichomonas vaginalis, also known as trich, causes no symptoms in about 70% of those infected. Even when asymptomatic, trich is linked to a host of bad health outcomes, including increased susceptibility to HIV, prostate cancer in men and infertility and pregnancy complications in women.
Trich is easily curable with a drug called metronidazole, if diagnosed, and WSU researcher John Alderete has been working for years to improve testing and make it more accessible. His latest development, detailed in the journal Pathogens, is a new finger-prick test that delivers results in five minutes and can be produced for under $20.
“We know a lot about the biology of this organism,” said Alderete, the study lead author and professor in WSU’s School of Molecular Biosciences. “There probably will never be a vaccine for trich simply because the organism is well equipped to evade our immune responses. But I’d argue we don't need a vaccine. We just need to diagnose people, and once diagnosed, they can be cured.”
Currently trich is often only diagnosed when symptoms are present, which can include genital itchiness and a burning sensation during urination. The tests in use now are focused on diagnosing women and involve a vaginal swab. It takes time to get results, and the tests require trained personnel as well as specialized equipment. Other methods recently approved by the Food and Drug Administration also have similar limitations.
As detailed in this study, the new test requires only a drop of blood to detect an antibody specific to trich. Alderete previously identified this biomarker, an alpha-actinin protein unique to this organism named ACT::SOE3 in earlier research. Both men and women make the antibody when they are infected.
Alderete, working with co-author Hermes Chan from the company MedMira, used the diagnostic platform of the company for his finger-prick test to detect for antibody to the target protein. Similar to COVID-19 and pregnancy tests, the results are displayed in a window with a dot appearing if the antibody is present, indicating infection. It is a point-of-care diagnostic test meaning positive results lead to immediate treatment and cure of a person. The test does not require specialized training and equipment to administer.
The goal was to meet World Health Organization “ASSURED” standards for disease detection, which stands for affordable, sensitive, specific, user-friendly, rapid and robust, equipment-free and deliverable to end users. Since trich is a world-wide problem with an estimated 156 million new cases each year, Alderete hopes the test can ultimately be used in many low-resource countries, particularly in places like Africa where trich is suspected to be a contributing factor in the spread of HIV.
The test can also have many benefits in the U.S. as well. Alderete estimated there are more than 9.2 million cases annually based on incidence rates and census data. . One study found that 50% of pregnant women had persistent undiagnosed infections – a significant concern since trich is associated with pre-term membrane rupture, preterm birth and low infant birth weight.
The first step is to make more people aware of the problem, Alderete said.
“Trich is the most common STI you've probably never heard of,” he said. “This STI may be the most neglected among the other curable STIs. We just have not done a good job in medicine to educate people. One of the major problems is that most people are asymptomatic. In other words, you may have it, but you don't know you have it until you have a really bad problem.”
Patent protection on the new development is in process.
END
Finger-prick test developed for ‘trich’ a common, undiagnosed STI
2023-03-27
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Surprise effect: Methane cools even as it heats
2023-03-27
Most climate models do not yet account for a new UC Riverside discovery: methane traps a great deal of heat in Earth’s atmosphere, but also creates cooling clouds that offset 30% of the heat.
Greenhouse gases like methane create a kind of blanket in the atmosphere, trapping heat from Earth’s surface, called longwave energy, and preventing it from radiating out into space. This makes the planet hotter.
“A blanket doesn’t create heat, unless it’s electric. You feel warm because ...
A puff of air could deliver your next vaccine (video)
2023-03-27
INDIANAPOLIS, March 27, 2023 — Nobody likes needles, but they’re necessary for delivering many vaccines and biologics into the body. But what if those could be puffed through the skin instead, with just a little pressure, like being hit in the arm with a foam toy? Today, scientists report steps toward making that a reality. Using powdered vaccines that don’t require refrigeration and a system driven by compressed gas, their “MOF-Jet” could easily deliver therapeutics against cancer and other diseases in a relatively painless way.
The researchers will present their results at the spring meeting of the American Chemical Society (ACS). ACS ...
Human cells help researchers understand squid camouflage
2023-03-27
INDIANAPOLIS, March 27, 2023 — Squids and octopuses are masters of camouflage, blending into their environment to evade predators or surprise prey. Some aspects of how these cephalopods become reversibly transparent are still “unclear,” largely because researchers can’t culture cephalopod skin cells in the lab. Today, however, researchers report that they have replicated the tunable transparency of some squid skin cells in mammalian cells, which can be cultured. The work could not only shed light on basic squid biology, but ...
Genetic tests unexpectedly find genes linked to heart disease — now what?
2023-03-27
Statement Highlights:
As health care professionals, researchers and consumers increasingly use genetic testing, they are uncovering incidental genetic abnormalities, or variants, that are associated with cardiovascular diseases.
The statement writing committee cautions that incidentally identified single gene variants may or may not be risk factors for disease, so it is important to interpret them correctly and cautiously.
The new scientific statement offers a framework to support health care professionals in appropriately assessing individual genetic variants, communicating findings with patients and families, and, when ...
Biochar and energy from pyrolysis can pave the way for carbon-neutral agriculture in China
2023-03-27
Since the Paris Agreement to combat global warming was reached in 2015, many countries have committed to becoming climate neutral, i.e., achieving net-zero greenhouse gas emissions. The world's largest agricultural country, China, is also committed to join the green transition. As the largest agricultural country, China is also the world's biggest emitter of greenhouse gases, yet it has set itself a target of achieving carbon neutrality by 2060.
According to Professor and Head of Land-CRAFT at Department of Agroecology at Aarhus University Klaus Butterbach-Bahl, this places huge demands on agricultural systems: "Agriculture in China accounts ...
Two striking new species of carnivorous plants discovered in the Andes of Ecuador
2023-03-27
A team of botanists from Ecuador, Germany, and the United States has described two new species of carnivorous plants with striking appearance. They are part of the butterworts (genus Pinguicula), a group of flowering plants with about 115 species that can catch and digest small insects with their sticky leaves. Whereas the majority of butterwort species is distributed in the northern hemisphere, these new species were discovered in the high Andes of southern Ecuador, close to the border with Peru.
Carnivorous plants use animals (usually small insects) as an additional source of nutrients ...
Global population could peak below 9 billion in 2050s
2023-03-27
The new projection is significantly lower than several prominent population estimates, including those of the United Nations. The researchers go further to say that if the world takes a “Giant Leap” in investment in economic development, education and health then global population could peak at 8.5 billion people by the middle of the century.
The new projections by researchers from the Earth4All initiative for the Global Challenges Foundation is published as a working paper People and Planet, 21st Century Sustainable Population Scenarios and Possible Living Standards Within Planetary Boundaries.
The team used a new system ...
Looking from different perspectives! Proper electronic structure of near-infrared absorbing functional dyes discovered
2023-03-27
Near-infrared light, whose wavelength is longer than visible light, is invisible and can pass through many substances. Organic materials that efficiently absorb near-infrared light are essential for technological innovations that utilize near-infrared light, such as the dyes in the infrared blocking filters of smartphone cameras and security inks. These and many more technical applications make developing new dyes that can absorb longer wavelengths of near-infrared light desirable.
Previously, near-infrared absorbing organic materials were treated as closed-shell molecules without unpaired electrons. However, a joint research group led by Associate Professor Takeshi Maeda, Assistant Professor ...
Bodies of people with mental illness are biologically older than their actual age
2023-03-27
New research shows that people with a lifetime history of mental disorders such as depression, bipolar disorder, or anxiety disorders have blood markers suggesting that they are older than their actual age. This may go some way to explaining why people with mental health problems tend to have shorter lifespans and more age-related diseases than the general population.
Dr Julian Mutz and Prof Cathryn Lewis, from King’s College London, looked at data on 168 different blood metabolites from 110,780 participants in the UK Biobank2. They linked these data to information on whether individuals had a history of mental illness and found that those with a mental illness ...
Study identifies two promising molecular targets for drug development in recurrent and metastatic cervical cancer
2023-03-27
NRG Oncology GOG-0240 is the phase 3 randomized trial which demonstrated that the incorporation of bevacizumab with chemotherapy resulted in a statistically significant and clinically meaningful survival benefit for women with recurrent and metastatic cervical carcinoma (NCT00803062). GOG-0240 was a proof of concept in anti-angiogenesis therapy and a proof of principle in supportive care and led directly to an indication for bevacizumab in this disease in over 60 countries. Whole genome sequencing and whole exome sequencing of tumor samples obtained in GOG-0240 suggest that ARID1A and PIK3CA could represent potential targets ...